Vikas Lifecare raised Rs 50 crore via QIP from Forbes EMF, Nomura & AG Dynamic
Qualified Institutional Buyers, QIBs, funding, QIP, QIP, Vikas Lifecare, Forbes, EMF, Nomura, AG Dynamic, Event Management Framework, Companies News, Business News,
Stay updated with breaking news from Vikas Multicorp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Qualified Institutional Buyers, QIBs, funding, QIP, QIP, Vikas Lifecare, Forbes, EMF, Nomura, AG Dynamic, Event Management Framework, Companies News, Business News,
New Delhi [India], June 6 (ANI/PNN): The company board of Vikas Lifecare Limited has approved the issuance and allotment of 12.50 crore equity shares to eligible, qualified institutional buyers (QIBs)
On Friday’s trading, the Indian indices were volatile and closed slightly lower. BSE Sensex closed at 61,223.03 levels down by 12 points. On the...
At meeting held on 06 February 2021The Board of Vikas Multicorp at its meeting held on 06 February 2021 has approves raising of funds by issue and allotment of equity shares aggregating up to Rs 50 crore by way of rights issue. The Board also approved fund raising up to Rs 50 crore by way of issuance of securities, convertible instruments, FCCBs, QIP / preferential allotment etc in one or more tranches. Further, the Board approved increase in authorised share capital of the company to Rs 100 crore and consequent alteration in capital clause of the Memorandum of Association. Powered by Capit...
On 06 February 2021The Board of Vikas Multicorp will meet on 06 February 2021 to consider fund raising up to Rs. 100 crore by way issuance of securities, convertible instruments, FCCB, QIP/Preferential Allotment including issue of securities on Rights Basis to the existing shareholder of the company. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader, Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and...